176 related articles for article (PubMed ID: 20833543)
1. Synthesis and biological evaluation of novel triptolide analogues for anticancer activity.
Zhou B; Miao Z; Deng G; Ding J; Yang Y; Feng H; Li Y
Bioorg Med Chem Lett; 2010 Nov; 20(21):6217-21. PubMed ID: 20833543
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
Xu H; Tang H; Feng H; Li Y
ChemMedChem; 2014 Feb; 9(2):290-5. PubMed ID: 24339424
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of novel D-ring-modified triptolide analogues: structure-cytotoxic activity relationship studies on the D-ring of triptolide.
Zhou B; Li X; Tang H; Miao Z; Feng H; Li Y
Org Biomol Chem; 2011 May; 9(9):3176-9. PubMed ID: 21409265
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
Li Z; Zhou ZL; Miao ZH; Lin LP; Feng HJ; Tong LJ; Ding J; Li YC
J Med Chem; 2009 Aug; 52(16):5115-23. PubMed ID: 19637874
[TBL] [Abstract][Full Text] [Related]
5. Semisynthesis of C-ring modified triptolide analogues and their cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2006 Apr; 16(7):1947-9. PubMed ID: 16455242
[TBL] [Abstract][Full Text] [Related]
6. [Progress in structure modification of triptolide].
Zhang F; Li YC
Yao Xue Xue Bao; 2004 Oct; 39(10):857-64. PubMed ID: 15700832
[No Abstract] [Full Text] [Related]
7. Semisynthesis of triptolide analogues: effect of γ-lactone and C-14 substituents on cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2011 May; 21(10):3046-9. PubMed ID: 21470864
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anticancer activity evaluation of novel C14 heterocycle substituted epi-triptolide.
Xu H; Tang H; Feng H; Li Y
Eur J Med Chem; 2014 Feb; 73():46-55. PubMed ID: 24378709
[TBL] [Abstract][Full Text] [Related]
9. Triptolide and its expanding multiple pharmacological functions.
Liu Q
Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.
Wong KF; Chan JK; Chan KL; Tam P; Yang D; Fan ST; Luk JM
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):55-9. PubMed ID: 18047628
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
12. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
[TBL] [Abstract][Full Text] [Related]
13. Antitumor agents 251: synthesis, cytotoxic evaluation, and structure-activity relationship studies of phenanthrene-based tylophorine derivatives (PBTs) as a new class of antitumor agents.
Wei L; Brossi A; Kendall R; Bastow KF; Morris-Natschke SL; Shi Q; Lee KH
Bioorg Med Chem; 2006 Oct; 14(19):6560-9. PubMed ID: 16809043
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits interferon-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells.
Liang M; Fu J
Cancer Lett; 2008 Nov; 270(2):337-41. PubMed ID: 18572307
[TBL] [Abstract][Full Text] [Related]
15. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
Zhou ZL; Yang YX; Ding J; Li YC; Miao ZH
Nat Prod Rep; 2012 Apr; 29(4):457-75. PubMed ID: 22270059
[TBL] [Abstract][Full Text] [Related]
16. [Progress in research on triptolide].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):170-4. PubMed ID: 15719629
[TBL] [Abstract][Full Text] [Related]
17. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X
Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869
[TBL] [Abstract][Full Text] [Related]
18. Semisynthesis of triptolide analogues: effect of B-ring substituents on cytotoxic activities.
Xu H; Chen Y; Tang H; Feng H; Li Y
Bioorg Med Chem Lett; 2014 Dec; 24(24):5671-5674. PubMed ID: 25467158
[TBL] [Abstract][Full Text] [Related]
19. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway.
Zhu W; Ou Y; Li Y; Xiao R; Shu M; Zhou Y; Xie J; He S; Qiu P; Yan G
Mol Pharmacol; 2009 Apr; 75(4):812-9. PubMed ID: 19158360
[TBL] [Abstract][Full Text] [Related]
20. Fluorination of triptolide and its analogues and their cytotoxicity.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Matsuyama S; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2008 Apr; 18(7):2459-63. PubMed ID: 18321701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
